AGYTF Projected Dividend Yield
Allergy Therapeutics Plc ( OTCBB : AGYTF )Allergy Therapeutics is engaged in immunology business with experience in the research and development of allergy treatments. Co. focuses on new pipeline products such as VLP peanut and marketed products for reactions to allergens such as house dust mites, venom and pollens. Co. sells a range of aluminium-free allergy therapies and diagnostics. Co. sells both injectable and sublingual (oral) formats. The commonly prescribed are those for the treatment of pollen related allergies, particularly for allergies to grasses, weeds and trees. Co.'s therapies trade under various brand names depending on the market, e.g. Pollinex Quattro, Polligoid and TA Graser Top. 20 YEAR PERFORMANCE RESULTS |
AGYTF Dividend History Detail AGYTF Dividend News AGYTF Competitors News |
Year |
Declaration Date |
Ex-Dividend Date |
Record Date |
Payable Date |
Dividend $ Amount |
Total: |
0.0000 |